An overview of chronic lymphocytic leukaemia biology

被引:19
作者
Bertilaccio, M. T. S. [2 ]
Scielzo, C. [2 ,4 ]
Muzio, M. [2 ]
Caligaris-Cappio, F. [1 ,2 ,3 ]
机构
[1] Univ Vita Salute San Raffaele, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Div Mol Oncol, Lab Lymphoid Malignancies, Milan, Italy
[3] Ist Sci San Raffaele, Dept Oncol, Unit Lymphoid Malignancies, Milan, Italy
[4] Univ Milan, I-20133 Milan, Italy
关键词
B-cell receptor; microenvironment; mouse models; B-CELL ACTIVATION; CD38; EXPRESSION; MOUSE MODEL; ZAP-70; INDUCE EXPRESSION; TRANSGENIC MOUSE; CLL PATIENTS; SURFACE IGM; IN-VIVO; APOPTOSIS;
D O I
10.1016/j.beha.2009.12.005
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and stimuli originating from the microenvironment concur to the selection and expansion of the malignant clone. Several lines of evidence, including molecular and functional analysis of the monoclonal immunoglobulin, support the hypothesis that stimulation through the B-cell receptor affects life and death of leukaemic cells. The microenvironment also has a critical role in the survival and accumulation of leukaemic cells within lymphoid organs where signals delivered from the surrounding cells are likely crucial in inducing proliferation. Nevertheless, several major biological issues still remain to be solved including regulation of the balance between proliferation and survival of leukaemic cells and the links between emerging gene abnormalities and microenvironment. In this context, mouse models are helpful tools in understanding disease mechanisms and in evaluating the efficacy of novel therapeutic agents. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 107 条
[1]
CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity [J].
Ansel, KM ;
Harris, RBS ;
Cyster, JG .
IMMUNITY, 2002, 16 (01) :67-76
[2]
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression [J].
Bichi, R ;
Shinton, SA ;
Martin, ES ;
Koval, A ;
Calin, GA ;
Cesari, R ;
Russo, G ;
Hardy, RR ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6955-6960
[3]
BRUNATI AM, 1995, EUR J BIOCHEM, V229, P164, DOI 10.1111/j.1432-1033.1995.0164l.x
[4]
Burger JA, 2000, BLOOD, V96, P2655
[5]
BURGER JA, 2009, BLOOD 0727
[6]
Buske C, 1997, EXP HEMATOL, V25, P329
[7]
Role of the microenvironment in chronic lymphocytic leukaemia [J].
Caligaris-Cappio, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) :380-388
[8]
ROMA illuminates CLL genomic lesions [J].
Caligaris-Cappio, Federico .
BLOOD, 2009, 113 (06) :1209-1210
[9]
INFREQUENT NORMAL LYMPHOCYTES-B EXPRESS FEATURES OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
CALIGARISCAPPIO, F ;
GOBBI, M ;
BOFILL, M ;
JANOSSY, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (02) :623-628
[10]
CALIGARISCAPPIO F, 1986, BLOOD, V67, P233